Hospitals & Diagnostics · Medical/Nursing Services · NSE: PRAMODINI · data 2026-11-03
Pramodini Medicare Limited
In plain words
Price: 22.6% below its 52-week high of ₹137.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | — |
| Net profit (last 12 months) | — |
| Sales growth, 3 years (yearly) | 26.8% |
| Profit growth, 3 years (yearly) | 59.5% |
At a glance
ROE 40.5%, ROCE 42.6%: how much profit it earns on the money it uses.
Debt/equity 0.34, Profit growth 59.5% and sales growth 26.8% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
- High return on equity (40.5%).
- Profit grew 59.5% a year over 3 years.
None flagged by these rules.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Smart-money activity
5/100 · Weak over the last ~60 sessions
- Delivery vs usual 0/30: No stored daily delivery history for this stock (0 points).
- Bulk/block deals 0/20: Net −₹3.6 cr in bulk/block deals over 90 days (0 net buying days, 1 net selling day): more sold than bought.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Deal
- 16 Sept 26Deal Bulk deal: NIRAJ RAJNIKANT SHAH sold ₹3.6 cr +0.4% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Common questions
Is Pramodini Medicare Limited debt-free?
Its latest reported debt-to-equity ratio is 0.34.
What is the 52-week high and low of Pramodini Medicare Limited?
The 52-week high is ₹137 and the 52-week low is ₹104.
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Pramodini Medicare Limited | ₹106 | ₹235 cr | — | 4.4 | 40.5% | 42.6% | 0.34 | -11.7% |
| Gaudium IVF & Women Health Ltd. | ₹105.64 | ₹770 cr | — | — | 24.7% | 35% | 0.16 | +27.3% |
| CHANDAN HEALTHCARE LIMITED | ₹234.75 | ₹575 cr | — | — | 18.4% | 23.4% | 0.31 | -27.8% |
| Rays of Belief Limited | ₹257.36 | ₹513 cr | — | — | — | — | — | +7.7% |
| Lotus Eye Hospital And Institute Ltd | ₹108.96 | ₹221 cr | 1,517.6 | — | 0.1% | -0.3% | 0.26 | -8.4% |
| Vaidya Sane Ayurved Laboratories Limited | ₹136 | ₹143 cr | 15.9 | 1.6 | 12% | 12% | 0.03 | -48.7% |
Compare PRAMODINI with GAUDIUMIVF in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open PRAMODINI in TickerKhoj →